CG-VAK: Directors Recommend 10% Dividend of ₹1 Per Share
CG-VAK Software and Exports Limited has announced that its Directors have recommended a dividend of ₹1 per equity share, representing a 10%…
Orchid Pharma: Appoints Arjun Dhanuka as Whole-Time Director
Orchid Pharma Limited announced the appointment of Mr. Arjun Dhanuka as a Whole-Time Director during its Board Meeting on September 03, 2026.…
Ceigall India: Discloses AGM Details and Annual Report Access
Ceigall India Limited has issued a notice regarding its 24th Annual General Meeting (AGM), scheduled for Tuesday, September 29, 2026, at 02:30…
Puravankara: Reports Record FY26 Sales of ₹7,407 Crore, Turns Profitable
Puravankara Limited has announced a landmark financial year 2025-26, marked by record-breaking sales of ₹7,407 crore, a significant increase…
Ceigall India: Reports Strong Financials for FY 2025-26, Outlines Growth Strategy
Ceigall India Limited has released its Annual Report for the Financial Year 2025-2026, highlighting robust financial performance and outlining…
Nilachal Refractories: Sets Record Date for 49th AGM
Nilachal Refractories Limited has announced the record date for its 49th Annual General Meeting (AGM). The 19th of September, 2026, has been…
Orchid Pharma: Board Appoints Arjun Dhanuka as Whole-Time Director
Orchid Pharma Limited’s Board of Directors convened on September 03, 2026, approving key appointments and forward-looking financial…
Pharmaasia Ltd.: Posts ₹1757 Cr Net Profit in FY26, Up From Loss
Pharmaasia Limited announced a substantial turnaround in its financial performance for the fiscal year ended March 31, 2026. The company…
Cohance Lifesciences: Invests $18 Million in NJ Bio and Aruka Bio for ADC Strategy
Cohance Lifesciences Limited is set to strengthen its Antibody-drug Conjugate (ADC) strategy with two proposed transactions: an additional $13…
Cipla: Partners Qilu Pharma for US Biosimilar Launch
Cipla Limited has announced an exclusive partnership with Qilu Pharmaceutical for the licensing and supply of QL2107, a biosimilar to…